Improving Outcomes in the Treatment and Management of Metastatic Colorectal Cancer - International White Paper Launched at European Cancer Congress 2013
AMSTERDAM, Sept. 28, 2013 /PRNewswire/ -- The Angiogenesis Foundation released a white paper at the 2013 European Cancer Congress that addresses the needs, challenges, and proposed solutions for improving treatment of metastatic colorectal cancer (mCRC), the third most common cancer among men and the second most common among women worldwide. The white paper, "Improving Outcomes in the Treatment and Management of Metastatic Colorectal Cancer," is the result of the International Expert Summit for mCRC, convened by the Angiogenesis Foundation in Berlin, Germany, this past July, that gathered a global multidisciplinary group of leading experts on the field.
New targeted drugs that have been approved since 2004 have shifted oncologists' approach to treating mCRC, and the standard of care now involves treatments aimed at interfering with angiogenesis—new blood vessel growth—which supplies tumors with oxygen and nutrients. Antiangiogenic treatments have increased both the survival and quality of life for patients suffering from this disease.
"With the advent of antiangiogenic therapy, metastatic CRC can now be approached as a cancer with multiple treatment options over time— choices that can improve a patient's quality of life. However, the benefit of these treatments has yet to be maximized and optimal care needs to be more accessible to all patients," commented Dr. William Li, President and Medical Director of the Angiogenesis Foundation.
This white paper addresses the current state of the field, identifies future goals and the barriers to those goals, and makes recommendations for advocacy leaders, oncologists, and the cancer community at large for improving patient outcomes worldwide. The white paper is being distributed at the European Cancer Congress at the Angiogenesis Foundation's advocacy booth, and can be downloaded at www.scienceofcrc.org/mCRC-globalwhitepaper.
The Angiogenesis Foundation (www.angio.org) is a nonprofit organization based in Cambridge, MA, USA that works with multiple stakeholders and leads international programs to improve health through treatments based on angiogenesis, the process of new blood vessel growth.
SOURCE The Angiogenesis Foundation
More by this Source
The Angiogenesis Foundation Receives Highest Rating from Charity Navigator
Nov 07, 2013, 08:23 ET
Angiogenesis Foundation veröffentlicht auf dem 13. Euretina Congress internationale Informationsschrift über die Fortschritte bei der Behandlung der altersbedingten feuchten Makuladegeneration
Sep 28, 2013, 06:23 ET
Verbesserung der Ergebnisse bei der Behandlung und Kontrolle von metastasierendem Dickdarm- und Enddarmkrebs - Internationales Weißbuch auf dem Europäischen Krebskongress 2013 veröffentlicht
Sep 28, 2013, 01:17 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.